チミジン一リン酸 TMP
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/05/16 14:12:57」(JST)
[Wiki en表示]
Thymidine monophosphate
|
|
Names |
IUPAC name
Thymidine monophosphate
|
Identifiers |
Abbreviations |
TMP |
Beilstein Reference
|
3916216 |
ChEBI |
CHEBI:26999 Y |
ChEMBL |
ChEMBL394429 N |
ChemSpider |
10239189 Y |
InChI
-
InChI=1S/C10H15N2O8P/c1-5-3-12(10(15)11-9(5)14)8-2-6(13)7(20-8)4-19-21(16,17)18/h3,6-8,13H,2,4H2,1H3,(H,11,14,15)(H2,16,17,18)/p-2 N
Key: GYOZYWVXFNDGLU-UHFFFAOYSA-L N
|
Jmol-3D images |
Image |
PubChem |
16755631 |
SMILES
-
Cc1cn(C2CC(O)C(COP([O-])([O-])=O)O2)c(:o)[nH]c1:o
|
Properties |
Chemical formula
|
C10H13N2O8P1− |
Molar mass |
322.2085 g mol−1 |
Except where noted otherwise, data is given for materials in their standard state (at 25 °C (77 °F), 100 kPa)
|
N verify (what is: Y/N?) |
Infobox references |
|
|
Thymidine monophosphate, also known as 5'-thymidylate, thymidylate, or TMP, is a nucleotide that is used as a monomer in DNA. It is an ester of phosphoric acid with the nucleoside thymidine. TMP consists of a phosphate group, the pentose sugar deoxyribose, and the nucleobase thymine. Unlike the other deoxyribonucleotides, thymidine monophosphate does not contain the "deoxy" prefix in its name.[1] As a substituent, it takes the form of the prefix thymidylyl-.
See also
- Nucleoside
- Nucleotide
- DNA
- RNA
- Oligonucleotide
References
- ^ Coghill, Anne M.; Garson, Lorrin R., ed. (2006). The ACS style guide: effective communication of scientific information (3rd ed.). Washington, D.C.: American Chemical Society. p. 244. ISBN 978-0-8412-3999-9.
External links
Nucleic acid constituents
|
|
Nucleobase |
- Purine
- Adenine
- Guanine
- Hypoxanthine
- Xanthine
- Purine analogue
- Pyrimidine
- Uracil
- Thymine
- Cytosine
- Pyrimidine analogue
- Unnatural base pair (UBP)
|
|
Nucleoside |
Ribonucleoside |
- Adenosine
- Guanosine
- 5-Methyluridine
- Uridine
- Cytidine
- Inosine
- Xanthosine
|
|
Deoxyribonucleoside |
- Deoxyadenosine
- Deoxyguanosine
- Thymidine
- Deoxyuridine
- Deoxycytidine
- Deoxyinosine
- Deoxyxanthosine
|
|
|
Nucleotide
(Nucleoside monophosphate) |
Ribonucleotide |
- AMP
- GMP
- m5UMP
- UMP
- CMP
- IMP
- XMP
|
|
Deoxyribonucleotide |
- dAMP
- dGMP
- dTMP
- dUMP
- dCMP
- dIMP
- dXMP
|
|
Cyclic nucleotide |
|
|
|
Nucleoside diphosphate |
|
|
Nucleoside triphosphate |
- ATP
- GTP
- m5UTP
- UTP
- CTP
- ITP
- XTP
|
|
- dATP
- dGTP
- dTTP
- dUTP
- dCTP
- dITP
- dXTP
|
|
|
Index of biochemical families
|
|
Carbohydrates |
- Alcohols
- Glycoproteins
- Glycosides
|
|
Lipids |
- Eicosanoids
- Fatty acids
- Glycerides
- Phospholipids
- Sphingolipids
- Steroids
|
|
Nucleic acids |
|
|
Proteins |
|
|
Other |
- Tetrapyrroles
- intermediates
|
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- TAOK3 phosphorylates the methylenecyclopropane nucleoside MBX 2168 to its monophosphate.
- Komazin-Meredith G1, Cardinale SC2, Comeau K2, Magalhaes KJ2, Hartline CB3, Williams JD2, Opperman TJ2, Prichard MN3, Bowlin TL2.
- Antiviral research.Antiviral Res.2015 Jul;119:23-7. doi: 10.1016/j.antiviral.2015.04.001. Epub 2015 Apr 7.
- Monohydroxymethyl methylenecyclopropane nucleosides (MCPNs) with ether or thioether substituents at the 6-position show promise as broad-spectrum herpes virus inhibitors. Their proposed mechanism of action involves sequential phosphorylation to a triphosphate, which can then inhibit viral DNA polyme
- PMID 25857706
- Kinetico-Mechanistic Studies of Nucleoside and Nucleotide Substitution Reactions of Co(III) Complexes of Fully Alkylated Cyclen.
- Martínez M1, Vázquez M1.
- Inorganic chemistry.Inorg Chem.2015 May 18;54(10):4972-80. doi: 10.1021/acs.inorgchem.5b00581. Epub 2015 May 6.
- The solution chemistry of complex [Co{(Me)2(μ-ET)cyclen}(H2O)2](3+) containing a fully substituted tetraammine ligand designed for the avoidance of base-conjugated substitution mechanisms in the 6-8 pH range has been studied. The study should shed some light on the possible involvement of such Co(I
- PMID 25943135
- Structural and Kinetic Characterization of Thymidine Kinase from Leishmania major.
- Timm J1, Bosch-Navarrete C2, Recio E2, Nettleship JE3, Rada H3, González-Pacanowska D2, Wilson KS1.
- PLoS neglected tropical diseases.PLoS Negl Trop Dis.2015 May 15;9(5):e0003781. doi: 10.1371/journal.pntd.0003781. eCollection 2015.
- Leishmania spp. is a protozoan parasite and the causative agent of leishmaniasis. Thymidine kinase (TK) catalyses the transfer of the γ-phosphate of ATP to 2'-deoxythymidine (dThd) forming thymidine monophosphate (dTMP). L. major Type II TK (LmTK) has been previously shown to be important for infec
- PMID 25978379
Japanese Journal
- <b>Orotate phosphoribosyltransferase localizes to the Golgi complex and its expression levels affect the sensitivity to anti-cancer drug 5-fluor</b><b>ouracil </b>
- Hydrogen Peroxide-Induced Thymidine Incorporation Into Cultured Rat Astrocytes
- Journal of pharmacological sciences 102(3), 296-304, 2006-11-20
- NAID 10020345080
- ラット再生肝における8-オキソ-2'-デオキシグアノシン除去エンドヌクレアーゼ
Related Links
- THYMIDINE 5'-MONOPHOSPHATE PRODUCT IDENTIFICATION CAS NO. 365-07-1 EINECS NO. 261-992-0 FORMULA C 10 H 15 N 2 O 8 P MOL WT. 322.21 H.S. CODE 5'- monofosfato de timidina (Spanish); PHYSICAL AND ...
- Buy Thymidine-5'-monophosphate, disodium salt (CAS 33430-62-5), a biochemical for proteomics research, from Santa Cruz. Purity: ≥99%,MW: 366.17 ... 物理的状態: Solid 溶解性: Soluble in water (100 mg/ml), and alcohol ...
★リンクテーブル★
[★]
- 英
- methotrexate, MTX
- ラ
- methotrexatum
- 同
- メソトレキサート、メトトレキセート
- 商
- トレキサメット、メソトレキセート、メトトレキサート、メトレート、リウマトレックス
- 関
- 他に分類されない代謝性医薬品
[show details]
- 免疫抑制薬
- 葉酸の4-amino-N10-methyl誘導体
作用機序
- 特にthymidine monophosphateの合成が阻害される (SPC.416)
- RNA、タンパク質合成を阻害するので、S期に移行しにくくなり薬効は低下
薬理作用
適用
副作用
- 胃炎、下痢。消化管穿孔
- 骨髄抑制、肝線維症、腎尿細管壊死、脱毛
- メトトレキサート腎症
関節リウマチの治療薬として用いられる場合の副作用
- 参考1
- 胃腸障害、口内炎、脱毛、肝機能障害
- (重篤な副作用)間質性肺炎(MTX肺炎)(0.5-5%)、骨髄障害(1-2%)、リンパ腫の発生
葉酸欠乏に伴う副作用
- https://minds.jcqhc.or.jp/docs/minds/MTX/05_ch4_MTX.pdf
- 症状:消化器症状(口内炎、下痢、食思不振)、肝酵素上昇、血球減少、脱毛など。用量依存性に出現する
- 治療の推奨:葉酸製剤の併用投与は、用量依存性副作用の予防や治療に有効であり、必要に応じて考慮する。MTX 8mg/週以上使用する場合や副作用リスクが高い症例(腎機能低下例、高齢者、複数のNSAIDs使用例)では葉酸併用投与が強く勧められる。葉酸製剤は5mg/週以内を、MTX最終投与後24-48時間以内に投与する。
注意
- 妊婦→妊娠初期三ヶ月における流産・奇形誘発
禁忌
添付文書
- http://www.info.pmda.go.jp/go/pack/4222400D2020_2_01/4222400D2020_2_01?view=body
参考
- 1. 関節リウマチの診療マニュアル(改訂版) 診断のマニュアルとEBMに基づく治療ガイドライン
- http://www.rheuma-net.or.jp/rheuma/rm400/library/guideline.html
- 2. 関節リウマチ治療におけるメトトレキサート(MTX)診療ガイドライン
- http://www.ryumachi-jp.com/info/guideline_mtx.html
[★]
- 英
- thymidine monophosphate, TMP
- 同
- チミジル酸 thymidylic acid thymidylate
- 関
- (DNA)デオキシチミジン一リン酸 deoxythymidine monophosphate dTMP
[★]
[★]
チミジル酸、チミジン一リン酸
- 関
- deoxythymidine monophosphate、dTMP、thymidine monophosphate、thymidylic acid
[★]
- 関
- dTMP、thymidine monophosphate、thymidylate、TMP
[★]
チミジン一リン酸、デオキシチミジン一リン酸
- 関
- dTMP、thymidine monophosphate、thymidylate
[★]